GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acusphere Inc (OTCPK:ACUS) » Definitions » Cyclically Adjusted Price-to-FCF

Acusphere (Acusphere) Cyclically Adjusted Price-to-FCF : (As of May. 19, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Acusphere Cyclically Adjusted Price-to-FCF?

Acusphere does not have a history long enough to calculate Cyclically Adjusted FCF per Share. Therefore GuruFocus does not calculate Cyclically Adjusted Price-to-FCF for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation


Acusphere Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Acusphere's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acusphere Cyclically Adjusted Price-to-FCF Chart

Acusphere Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial - - - - -

Acusphere Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Acusphere's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Acusphere's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acusphere's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acusphere's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Acusphere's Cyclically Adjusted Price-to-FCF falls into.



Acusphere Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Acusphere does not have a history long enough to calculate Cyclically Adjusted FCF per Share. Therefore GuruFocus does not calculate Cyclically Adjusted Price-to-FCF for this company.


Acusphere  (OTCPK:ACUS) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Acusphere Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Acusphere's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Acusphere (Acusphere) Business Description

Industry
Traded in Other Exchanges
N/A
Address
99 Hayden Avenue, Suite 385, Lexington, MA, USA, 02421
Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.
Executives
Martyn D Greenacre director 41 MOORES ROAD, FRAZER PA 19355
Garen G Bohlin director C/O PRAECIS PHARMACEUTICALS INC, 830 WINTER STREET, WALTHAM MA 02451
Sandra L Fenwick director C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Frederick W Ahlholm officer: VP Finance C/O MINERVA NEUROSCIENCES, INC., 1601 TRAPELO ROAD, SUITE 286, WALTHAM MA 02451
John F Thero other: Former Senior VP/CFO C/O AMARIN PHARMA, INC., 1430 ROUTE 6, BEDMINSTER NJ 07921
Kate Mitchell director 950 TOWER LANE, STE 700, FOSTER CITY CA 94404
Bank Of America Corp /de/ 10 percent owner BANK OF AMERICA CORPORATE CENTER, 100 N TRYON ST, CHARLOTTE NC 28255
Bank Of America Na 10 percent owner 100 N. TRYON STREET, CHARLOTTE NC 28255
Nb Holdings Corp 10 percent owner 100 NORTH TRYON STREET, CHARLOTTE NC 28255
Terrance Mcguire director C/O POLARIS VENTURE PARTNERS LP, 1000 WINTER STREET, SUITE 3350, WALTHAM MA 02154

Acusphere (Acusphere) Headlines

No Headlines